Bioplatforms Australia

EMBL Australia and Bioplatforms Australia have an agreement for EMBL Australia research teams to access key research facilities operated through the Bioplatforms Australia network.

The alliance aims to further collaboration and resource-sharing in the scientific community.

Bioplatforms Australia was established in 2007 under the National Collaborative Research Infrastructure Strategy (NCRIS) to manage a Commonwealth Government investment in the rapidly-expanding ‘-omics’ disciples.

Bioplatforms Australia acts as a co-ordinating body for four ‘omics consortiums that offer world class expertise and host state-of-the-art facilities and infrastructure:

• Genomics Australia: specialise in high throughput gene sequencing, transcript analysis, epigenetics, bioinformatics
• Proteomics Australia: specialist services for protein separation, mass spectrometry, monoclonal antibody development, protein chemistry
• Metabolomics Australia: specialise in small molecule analysis, sample preparation, metabolite profiling, mass spectrometry
• Australian Bioinformatics Facility: offers cutting edge computational tools and strategies for experiment planning, data acquisition, data analysis, data reporting

More information on Bioplatforms Australia, including its research facilities, can be found at:
www.bioplatforms.com.au